A Community-Based Screening Program for Chagas Disease in the USA
Related Experiment Video
Updated: Feb 25, 2026

08:48
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
3.9K
Sheba K Meymandi1, Salvador Hernandez1, Colin J Forsyth1
1Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, CA, USA.
Trends in Parasitology
|August 1, 2017
Abstract:
Chagas disease (CD) affects over 300 000 people in the USA, many with limited access to healthcare. Although early detection and treatment prevents life-threatening complications, <1% of people with CD receive diagnosis, and routine screening is virtually nonexistent in the USA. We describe a program that led to an increase in CD screening in the Latin American-born population of Los Angeles.

